Journal of Chiropractic Medicine
Volume 3, Issue 4 , Pages 160-163 , Autumn 2004

Vioxx®: What should we tell our patients?

  • Claire Johnson, MSEd, DC

      Affiliations

    • Corresponding Author Information200 E. Roosevelt Rd. Lombard, IL 60148

References 

  1. Fendrick AM . COX-2 Inhibitor Use After Vioxx: Careful Balance or End of the Rope? . Am J Manag Care [cited 2004 Nov 28] . 2004;10:740–741 Available from: http://www.ajmc.com/Article.cfm?Menu=1&ID=2754
  2. FDA/Center for Drug Evaluation and Research [homepage on the Internet]. Rockville MD [updated 2004 Sept 30; cited 2004 Nov
  3. Formanek R, editor. Merck Withdraws Vioxx; FDA Issues Public Health Advisory. [monograph on the Internet]. Rockville MD: FDA Consumer magazine 38(6) November-December 2004 [cited 2004 Nov]
  4. [homepage on the Internet]. Whitehouse Station, NJ. c1995–2004 [updated 2004 Sept 30; cited 2004 Nov 28] Merck announces voluntary worldwide withdrawal of VIOXX. (comsumers) . Available from: http://www.vioxx.com/rofecoxib/vioxx/consumer/index.jsp
  5. [homepage on the Internet]. Whitehouse Station, NJ. c1995–2004 [updated 2004 Sept 30; cited 2004 Nov 28] Merck announces voluntary worldwide withdrawal of VIOXX. (physicians) . Available from: http://www.vioxx.com/rofecoxib/vioxx/hcp/hcp_notification_physicians.jsp
  6. Topol EJ . Failing the public health – rofecoxib, Merck, and the FDA . N Engl J Med . Oct 21, 2004;351(17):1707–1709 Available from: Http://content.nejm.org/cgi/content/full/351/17/1707
  7. Patient Information about VIOXX (rofecoxib tablets and oral suspension) for Osteoarthritis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Pain and Migraine Attacks Generic name: rofecoxib. [monograph on the Internet] Whitehouse Station, NJ. [cited 2004 Nov 28] . Available from: http://www.vioxx.com/vioxx/documents/english/vioxx_ppi.pdf
  8. Mukherjee DM , Nissen SE , Topol EJ . Risk of cardiovascular events associated with selective COX-2 inhibitors . JAMA . 2001;286:954–959
  9. [homepage on the Internet]. Whitehouse Station, NJ. c1995–2004 [updated 2004 Sept 30; cited 2004 Nov 28] Important Information For Patients Taking VIOXX . Available Http://www.vioxx.com/rofecoxib/vioxx/consumer/patient_important_information.jsp
  10. FDA/Center for Drug Evaluation and Research [homepage on the Internet]. Rockville MD [updated 2004 Sept 30; cited 2004 Nov 28] Vioxx (rofecoxib) Questions and Answers . Available from: Http://www.fda.gov/cder/drug/infopage/vioxx/vioxxQA.htm
  11. Soeken KL . Clin J Pain. Selected CAM therapies for arthritis-related pain: the evidence from systematic reviews . Clin J Pain . 2004;20:13–18
  12. Descarreaux M , Blouin JS , Drolet M , Papadimitriou S , Teasdale N . Efficacy of preventive spinal manipulation for chronic low-back pain and related disabilities: a preliminary study . J Manipulative Physiol Ther . 2004;27:509–514
  13. McCarthy CJ , Mills PM , Pullen R , et al.   Supplementation of a homebased exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis . Health Technol Assess . 2004;8:1–76
  14. Vas J , Mendez C , Perea-Milla E , et al.   Acupuncture as a complementary therapy to the pharmacological treatment of osteoarthritis of the knee: randomised controlled trial . BMJ . 2004;20:1216; 329(7476):. Epub 2004 Oct 19
  15. Schiller L . Effectiveness of spinal manipulative therapy in the treatment of mechanical thoracic spine pain: a pilot randomized clinical trial . J Manipulative Physiol Ther . 2001;24:394–401

PII: S0899-3467(07)60104-9

doi: 10.1016/S0899-3467(07)60104-9

Journal of Chiropractic Medicine
Volume 3, Issue 4 , Pages 160-163 , Autumn 2004